Emmaus Life Sciences (EMMA) Stock Chart & Stock Price History → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free EMMA Stock Alerts $0.11 0.00 (0.00%) (As of 05/13/2024 ET) Add Compare Share Share ChartStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Emmaus Life Sciences Stock Price Performance5 Day Performance+5.00%1 Month PerformanceN/A3 Month Performance+0.96%6 Month Performance-12.50%Year-To-Date Performance+4.92%1 Year Performance-67.19% Receive EMMA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Emmaus Life Sciences and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceElon Musk’s Next Move Will Disrupt AI ForeverA revolutionary venture that is set to get rolled out by May 16. One well-connected Silicon Valley VC has uncovered a way for anybody to claim a stake in "Elon Musk's AI 2.0" with as little as $100.Get all the information here. EMMA Stock Chart for Tuesday, May, 14, 2024 EMMA Chart by TradingView Emmaus Life Sciences Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/09/2024$0.10$0.11+5.00%$0.11$0.11214 shs$6.71 million05/08/2024$0.11$0.10-9.09%$0.10$0.108,504 shs$6.39 million05/07/2024$0.11$0.11$0.11$0.112,000 shs$7.03 million05/06/2024$0.10$0.11+10.00%$0.11$0.112,000 shs$7.03 million05/03/2024$0.10$0.10$0.10$0.102,288 shs$6.19 million05/02/2024$0.10$0.10$0.10$0.102,654 shs$6.19 million Get the Latest News and Ratings for EMMA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Emmaus Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 04/26/2024$0.10$0.10$0.10$0.10654 shs$6.19 million04/25/2024$0.10$0.10$0.10$0.104,635 shs$6.19 million04/24/2024$0.09$0.10+8.57%$0.10$0.104,635 shs$6.19 million04/23/2024$0.09$0.09+0.01%$0.09$0.0933 shs$5.70 million04/22/2024$0.09$0.09-0.01%$0.10$0.0966,100 shs$5.70 million04/19/2024$0.11$0.09-19.03%$0.10$0.0966,100 shs$5.70 million04/18/2024$0.11$0.11$0.11$0.1141 shs$7.04 million04/17/2024$0.11$0.11-0.04%$0.11$0.1141 shs$7.04 million04/16/2024$0.11$0.11+8.38%$0.11$0.11300 shs$7.04 million04/10/2024$0.11$0.11-5.62%$0.11$0.113,520 shs$6.49 million04/09/2024$0.11$0.11+5.95%$0.11$0.11833 shs$6.88 million04/08/2024$0.11$0.11-5.41%$0.11$0.113,520 shs$6.49 million04/05/2024$0.11$0.11+6.00%$0.12$0.11833 shs$6.88 million04/04/2024$0.11$0.11-7.69%$0.11$0.11100 shs$6.49 million04/03/2024$0.11$0.11$0.11$0.11166 shs$7.04 million04/02/2024$0.11$0.11$0.11$0.11166 shs$7.04 million04/01/2024$0.11$0.11+8.33%$0.11$0.11166 shs$7.04 million03/29/2024$0.12$0.11-10.26%$0.13$0.115,333 shs$6.49 million03/28/2024$0.12$0.12$0.13$0.112,595 shs$7.24 million03/27/2024$0.09$0.12+30.00%$0.12$0.12215 shs$7.24 million03/25/2024$0.10$0.10$0.10$0.1026,901 shs$6.37 million03/22/2024$0.13$0.10-19.53%$0.12$0.1026,901 shs$6.37 million03/21/2024$0.09$0.13+42.22%$0.13$0.1010,410 shs$7.92 million03/20/2024$0.09$0.09+5.02%$0.09$0.091,151 shs$5.57 million03/19/2024$0.10$0.09-15.23%$0.09$0.09938 shs$5.30 million03/18/2024$0.10$0.10$0.10$0.105,000 shs$6.25 million03/15/2024$0.12$0.10-12.09%$0.11$0.1012,000 shs$6.25 million03/14/2024$0.12$0.12$0.13$0.1220,016 shs$7.11 million03/13/2024$0.11$0.12+3.05%$0.13$0.1220,016 shs$7.11 million03/12/2024$0.11$0.11+1.32%$0.11$0.10835 shs$6.90 million03/11/2024$0.11$0.11+1.33%$0.11$0.11110 shs$6.81 million03/08/2024$0.11$0.11-2.60%$0.11$0.111,863 shs$6.72 million03/07/2024$0.11$0.11-2.62%$0.11$0.11100 shs$6.90 million03/06/2024$0.10$0.11+13.47%$0.13$0.1012,939 shs$7.09 millionElon’s New Device is About to Shock the World (Ad)Using this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake.03/05/2024$0.11$0.10-8.18%$0.13$0.1013,766 shs$6.25 million03/04/2024$0.13$0.11-13.39%$0.13$0.0931,000 shs$6.80 million03/01/2024$0.12$0.13+7.08%$0.13$0.1321,000 shs$7.86 million02/29/2024$0.12$0.12-2.19%$0.13$0.12148,083 shs$7.34 million02/28/2024$0.13$0.12-6.66%$0.13$0.1215,000 shs$7.50 million02/27/2024$0.13$0.13-0.08%$0.13$0.1330,000 shs$8.03 million02/26/2024$0.11$0.13+18.18%$0.13$0.1114,661 shs$8.04 million02/23/2024$0.13$0.11-16.79%$0.12$0.1113,443 shs$6.80 million02/22/2024$0.09$0.13+51.95%$0.13$0.0818,835 shs$8.18 million02/21/2024$0.09$0.09$0.09$0.09300 shs$5.38 million02/20/2024$0.09$0.09$0.09$0.0910,000 shs$5.38 million02/19/2024$0.09$0.09$0.09$0.0827,200 shs$5.38 million02/16/2024$0.10$0.09-9.47%$0.09$0.0827,256 shs$5.38 million02/14/2024$0.10$0.10-7.60%$0.10$0.10100 shs$5.94 million02/13/2024$0.10$0.10$0.10$0.1010,000 shs$6.43 million02/12/2024$0.10$0.10+4.00%$0.10$0.1010,000 shs$6.43 million Related Companies: iBio Stock Chart Shuttle Pharmaceuticals Stock Chart TransCode Therapeutics Stock Chart Processa Pharmaceuticals Stock Chart Tenax Therapeutics Stock Chart Pulmatrix Stock Chart Theriva Biologics Stock Chart ASLAN Pharmaceuticals Stock Chart Can-Fite BioPharma Stock Chart Ainos Stock Chart Receive EMMA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Emmaus Life Sciences and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:EMMA) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersElon’s New Device is About to Shock the WorldInvestorPlaceTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe only AI company you should be looking atBehind the MarketsCharles Payne Demystifies OptionsUnstoppable ProsperityForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressNo experience to confident trader, meet my student…Wealth Builders InstituteCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOIC Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Emmaus Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.